Role of laparoscopy in benign ovarian tumour

2019 ◽  
Vol 11 (1) ◽  
pp. 01-03
Author(s):  
Suvarna Samir Bhopale ◽  
◽  
Shyam Shirsam ◽  
Keyword(s):  
Ovarian Tumour ◽  
Benign Ovarian Tumour

1097 Role of PD-L1 in In-vitro Interaction Between T-cells and Ovarian Tumour Cells

2012 ◽  
Vol 48 ◽  
pp. S264
Author(s):  
J. Chatterjee ◽  
N. Haslinda Abdul Aziz ◽  
C. Maine ◽  
C. Hayford ◽  
L. Whilding ◽  
...  
Keyword(s):  
T Cells ◽  
Ovarian Tumour ◽  
Tumour Cells ◽  
In Vitro Interaction

Spurious Elevation of Ca-125 in Benign Ovarian Tumour

2017 ◽  
Vol 6 (2(Part-1)) ◽  
pp. 327-329
Author(s):  
Vincy T.M. ◽  
◽  
Kanchana M.P. ◽  
Keyword(s):  
Ovarian Tumour ◽  
Ca 125 ◽  
Benign Ovarian Tumour

The role of progesterone-induced blocking factor (PIBF) in invasion of primary ovarian tumour cells

2017 ◽  
Vol 122 ◽  
pp. 46
Author(s):  
T. Balassa ◽  
G. Berta ◽  
N. Bohonyi ◽  
J. Szekeres-Barthó
Keyword(s):  
Ovarian Tumour ◽  
Tumour Cells ◽  
Blocking Factor

Serous cystadenoma of ovary with xanthogranulomatous oophoritis: combination of benign ovarian tumour with chronic inflammatory non-neoplastic pseudo-tumour-a rarity

2017 ◽  
Vol 6 (4) ◽  
pp. 1682
Author(s):  
Monika Anant ◽  
Kajal Sinha ◽  
Mukta Agarwal ◽  
Hemali H. Sinha ◽  
Punam Bhadani
Keyword(s):  
Chronic Inflammation ◽  
Female Genital Tract ◽  
Benign Neoplasm ◽  
Ovarian Tumour ◽  
Serous Cystadenoma ◽  
Rare Type ◽  
Macroscopic Appearance ◽  
Xanthogranulomatous Inflammation ◽  
Benign Ovarian Tumour ◽  
Female Genital

Xanthogranulomatous inflammation is a rare type of chronic inflammation. It destroys the tissue of the affected organ, mostly affecting the kidney and gall bladder. Xanthogranulomatous inflammation of female genital tract being a rare entity, only few numbered cases involving the ovary have been reported in literature. This chronic inflammation of fallopian tubes and ovaries, usually present with pelvic masses, and on imaging and macroscopic appearance, are mostly misdiagnosed as ovarian neoplasm or tuberculosis. We are presenting a case of 14-year-old girl, who presented with an abdominal lump and on clinical and radiological investigations was suspected as ovarian malignancy but histo-pathology reported it as serous cystadenoma with xanthogranulomaotus oophoritis. The rarity of this case lies in the fact that rare destructive inflammatory features was present in a benign neoplasm of the ovary (serous cystadenoma) and that too in a youngest age reported till now.

scholarly journals A rare benign ovarian tumour

2016 ◽  
pp. bcr2015214101 ◽  
Author(s):  
Marta Morna Palmeiro ◽  
Teresa Margarida Cunha ◽  
Ana Luisa Loureiro ◽  
Gonçalo Esteves
Keyword(s):  
Ovarian Tumour ◽  
Benign Ovarian Tumour

scholarly journals Metastatic Renal Cell Carcinoma in an Ovarian Benign Mixed Mucinous Cystadenoma and Brenner Tumour: A Case Report

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Amar Ibrahim ◽  
Mohammad Salih Al-Jafari
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Abdominal Mass ◽  
Mucinous Cystadenoma ◽  
Ovarian Tumour ◽  
Therapeutic Implications ◽  
Benign Ovarian Tumour ◽  
Rule Out

This is a case of a 71-year-old woman, who presented with a large abdominal mass. Microscopic examination revealed metastatic renal cell carcinoma in an otherwise massively enlarged benign ovarian tumour of mixed mucinous cystadenoma and Brenner tumour. Clinicopathological and radiological assessment together with a thorough evaluation of gross and histological features, including the use of immunohistochemical stains, is essential to confirm the diagnosis and rule out the possibility of primary clear cell carcinoma of ovary, as this has important prognostic and therapeutic implications.

scholarly journals Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
David Díaz-Carballo ◽  
Sahitya Saka ◽  
Ali H. Acikelli ◽  
Ekaterina Homp ◽  
Julia Erwes ◽  
...  
Keyword(s):  
Hdac Inhibitors ◽  
Ovarian Tumour ◽  
Endogenous Retroviruses ◽  
Antitumoral Activity ◽  
Cancer Therapies ◽  
Simultaneous Application ◽  
Human Endogenous Retroviruses ◽  
Shock And Kill ◽  
Latent Hiv

AbstractIn this work, we are reporting that “Shock and Kill”, a therapeutic approach designed to eliminate latent HIV from cell reservoirs, is extrapolatable to cancer therapy. This is based on the observation that malignant cells express a spectrum of human endogenous retroviral elements (HERVs) which can be transcriptionally boosted by HDAC inhibitors. The endoretroviral gene HERV-V2 codes for an envelope protein, which resembles syncytins. It is significantly overexpressed upon exposure to HDAC inhibitors and can be effectively targeted by simultaneous application of TLR7/8 agonists, triggering intrinsic apoptosis. We demonstrated that this synergistic cytotoxic effect was accompanied by the functional disruption of the TLR7/8-NFκB, Akt/PKB, and Ras-MEK-ERK signalling pathways. CRISPR/Cas9 ablation of TLR7 and HERV-V1/V2 curtailed apoptosis significantly, proving the pivotal role of these elements in driving cell death. The effectiveness of this new approach was confirmed in ovarian tumour xenograft studies, revealing a promising avenue for future cancer therapies.

Sign in / Sign up

Export Citation Format

Share Document